Eser Muhammed Taha, Hanalioglu Sahin, Cetiner Mehmet Ziya, Dinc Samet, Peker Halil Olgun, Sorar Mehmet, Dolgun Habibullah, Turkoglu Erhan
Health Sciences University, Diskapi Yildirim Beyazit Training and Research Hospital, Department of Neurosurgery, Ankara, Turkey.
Turk Neurosurg. 2019;29(3):377-385. doi: 10.5137/1019-5149.JTN.24432-18.0.
To investigate comparative efficacy of a novel absorbable adhesive membrane (TissuePatchDuralTM "TPD") and a fibrin glue (Tisseel "T") in reducing cerebrospinal fluid (CSF) leaks after posterior fossa and spinal procedures, and also to identify potential risk factors for CSF leakage.
This is a single-center, retrospective cohort study of 123 consecutive posterior fossa (n=77) and spinal (n=46) surgeries. Patients were grouped based on dural sealants used 2-group comparison: TPD (n=56) vs. no-TPD (n=67) and 3-group comparison: T only (n=43), TPD only (n=32) vs TPD+T (n=35).
Mean age was 38.9 ± 22.2 years (62 males, 61 females). Baseline characteristics were similar between groups. Neither 2-group (TPD: 10.4% vs no-TPD: 8.9%; p=0.778) nor 3-group (T: 9.3% vs TPD: 6.3% vs TPD+T: 14.3%; p=0.539) comparisons revealed a significant difference in postoperative CSF leakage rates. Multivariate analysis showed that diagnosis (non-tumoral vs. tumor) (OR: 5.487; 95% CI: 1.118-26.937; p=0.036); previous surgery (OR: 9.268; 95% CI: 1.911-44.958; p=0.006), postoperative hydrocephalus (OR: 5.456; 95% CI: 1.250-23.821; p=0.024) were independent predictors of postoperative CSF leakage.
TissuePatchDural < sup > TM < /sup > is a novel dural sealant patch which can be safely used to reinforce dural closure in posterior fossa and spinal surgeries, and its efficacy is comparable to widely used fibrin glue (Tisseel). Non-tumoral pathologies, previous surgery, and postoperative hydrocephalus appear to be independent risk factors for postoperative CSF leakage.
研究新型可吸收性黏附膜(TissuePatchDuralTM “TPD”)与纤维蛋白胶(Tisseel “T”)在后颅窝和脊柱手术后减少脑脊液(CSF)漏出方面的比较疗效,并确定脑脊液漏出的潜在危险因素。
这是一项对123例连续的后颅窝手术(n = 77)和脊柱手术(n = 46)进行的单中心回顾性队列研究。根据使用的硬脑膜封闭剂将患者分组,进行两组比较:TPD组(n = 56)与非TPD组(n = 67),以及三组比较:仅使用T组(n = 43)、仅使用TPD组(n = 32)与TPD + T组(n = 35)。
平均年龄为38.9 ± 22.2岁(男性62例,女性61例)。各组间基线特征相似。两组比较(TPD组:10.4% 对非TPD组:8.9%;p = 0.778)和三组比较(T组:9.3% 对TPD组:6.3% 对TPD + T组:14.3%;p = 0.539)均未显示术后脑脊液漏出率有显著差异。多因素分析显示,诊断(非肿瘤性与肿瘤性)(OR:5.487;95% CI:1.118 - 26.937;p = 0.036)、既往手术史(OR:9.268;95% CI:1.911 - 44.958;p = 0.006)、术后脑积水(OR:5.456;95% CI:1.250 - 23.821;p = 0.024)是术后脑脊液漏出的独立预测因素。
TissuePatchDuralTM是一种新型硬脑膜封闭剂贴片,可安全用于后颅窝和脊柱手术中加强硬脑膜闭合,其疗效与广泛使用的纤维蛋白胶(Tisseel)相当。非肿瘤性病变、既往手术史和术后脑积水似乎是术后脑脊液漏出的独立危险因素。